09.03.18
GERMANY: L’Oréal is acquiring Logocos Naturkosmetik AG, the German beauty company behind Logona and Sante. All of the company’s brands are vegan and bio-certified with a range of products using their own plant extracts and natural ingredients derived from organic farming.
Founded in 1978, Logocos Natur-kosmetik is based in Hanover, and employs about 340 people. In 2017, net sales were €59 million (approximately $67 million at current exchange rates) across Germany and other countries in Europe.
Logona products include hair care, hair color, skin care and hygiene, and are found in specialized distribution (mainly organic stores) at a premium price level that targets engaged consumers of natural cosmetics. The Sante line of products includes hair care, skin care, hygiene and makeup and is found mainly in mass retail at an accessible price for young and trendy consumers.
Logocos brings two authentic and certified naturaI brands as well as a unique expertise from a worldwide pioneer of the organic beauty market, according to Alexis Perakis-Valat, president of L’Oréal’s Consumer Products Division. “In line with L’Oréal’s strategy to ‘seize what starts,’ this acquisition reinforces the position of the Division on one of today’s major beauty ascending trends.”
In other company news, L’Oréal has submitted to the shareholders of Holding STRP (Société des Thermes de La Roche-Posay) an irrevocable offer for the acquisition of the totality of the shares of the company. The project foresees the prior carve out of the hotel business to the current shareholders of Holding STRP and the attribution of exclusive negotiation rights to L’Oréal.
Created in 1921, Société des Thermes de La Roche-Posay is the first thermal station in Europe exclusively dedicated to treating dermatological diseases. The thermal water of La Roche-Posay has therapeutic anti-inflammatory, healing and soothing properties to treat skin diseases like eczema, psoriasis, burn scars and cutaneous side effects of cancer treatments. In 2017, more than 7,500 patients have benefited from the thermal activity, generating sales of €3.6 million.
“This acquisition project will enable us to sustain and reinforce the dermatologic position of La Roche-Posay by developing the existing indications and making the thermal station a flagship for the brand,” said Laetitia Toupet, international general manager of La Roche-Posay.
Founded in 1978, Logocos Natur-kosmetik is based in Hanover, and employs about 340 people. In 2017, net sales were €59 million (approximately $67 million at current exchange rates) across Germany and other countries in Europe.
Logona products include hair care, hair color, skin care and hygiene, and are found in specialized distribution (mainly organic stores) at a premium price level that targets engaged consumers of natural cosmetics. The Sante line of products includes hair care, skin care, hygiene and makeup and is found mainly in mass retail at an accessible price for young and trendy consumers.
Logocos brings two authentic and certified naturaI brands as well as a unique expertise from a worldwide pioneer of the organic beauty market, according to Alexis Perakis-Valat, president of L’Oréal’s Consumer Products Division. “In line with L’Oréal’s strategy to ‘seize what starts,’ this acquisition reinforces the position of the Division on one of today’s major beauty ascending trends.”
In other company news, L’Oréal has submitted to the shareholders of Holding STRP (Société des Thermes de La Roche-Posay) an irrevocable offer for the acquisition of the totality of the shares of the company. The project foresees the prior carve out of the hotel business to the current shareholders of Holding STRP and the attribution of exclusive negotiation rights to L’Oréal.
Created in 1921, Société des Thermes de La Roche-Posay is the first thermal station in Europe exclusively dedicated to treating dermatological diseases. The thermal water of La Roche-Posay has therapeutic anti-inflammatory, healing and soothing properties to treat skin diseases like eczema, psoriasis, burn scars and cutaneous side effects of cancer treatments. In 2017, more than 7,500 patients have benefited from the thermal activity, generating sales of €3.6 million.
“This acquisition project will enable us to sustain and reinforce the dermatologic position of La Roche-Posay by developing the existing indications and making the thermal station a flagship for the brand,” said Laetitia Toupet, international general manager of La Roche-Posay.